Tet2 modulation in Aβ42-injured mouse hippocampal neurons

Exploratory Score: 0.900 Price: $0.50 Alzheimer's disease primary mouse hippocampal neurons Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting TET2 in primary mouse hippocampal neurons. Primary outcome: neuronal survival and morphology protection

Description

This in vitro experiment investigated the role of Ten eleven translocation-2 (Tet2) in protecting hippocampal neurons against amyloid-β42 oligomer-induced toxicity. Primary mouse hippocampal neurons were exposed to Aβ42 oligomers to create a model of neuronal injury. The researchers then used recombinant plasmids to either inhibit or overexpress Tet2 in these injured neurons. The study examined how modulating Tet2 expression levels affected neuronal survival and morphology under conditions of amyloid toxicity. Results showed that reduced Tet2 expression exacerbated neuronal damage, while increased Tet2 expression provided neuroprotection against Aβ42-induced toxicity.

TARGET GENE

TET2 (Score: 0.584)

MODEL SYSTEM

primary mouse hippocampal neurons

ESTIMATED COST

TIMELINE

0 months

PATHWAY

DNA demethylation/epigenetic regulation

SOURCE

extracted_from_pmid_33165916

PRIMARY OUTCOME

neuronal survival and morphology protection

Scoring Dimensions

📖 Wiki Pages

Protocol

Establish primary mouse hippocampal neurons cohorts for Alzheimer's disease and predefine inclusion, exclusion, and quality-control criteria before intervention. 2. Apply the experimental manipulation described for TET2, alongside matched control or comparator arms, and document dose, exposure window, and sample timing in a locked protocol log. 3. Measure neuronal survival and morphology protection together with orthogonal secondary readouts such as molecular, imaging, behavioral, or safety endpoints that are appropriate to the title and study design. 4. Use blinded outcome assessment where feasible, prespecified statistical analysis, and replicate the core readout across biological replicates or an independent validation subset. 5.

...

Expected Outcomes

The intervention targeting TET2 shifts neuronal survival and morphology protection in the predicted direction relative to the matched control arm.

Secondary disease-relevant readouts in Alzheimer's disease remain directionally concordant with the primary endpoint rather than showing isolated single-assay effects.

The effect persists after adjustment for baseline covariates, batch effects, or repeated-measures structure used in the study design.

Success Criteria

Prespecified primary endpoint (neuronal survival and morphology protection) improves versus control with p < 0.05 or an equivalent corrected threshold used by the study.
The effect size is biologically meaningful and reproduced across technical/biological replicates or the validation subset.
Safety, data quality, and missingness remain within protocol-defined bounds so the result is interpretable rather than driven by attrition or assay failure.

Related Hypotheses (5)

Gamma entrainment therapy to restore hippocampal-cortical synchrony0.851

Cell-Type Specific TREM2 Upregulation in DAM Microglia0.761

Epigenetic Memory Erasure via TET2 Activation0.741

TET2-Mediated Demethylation Rejuvenation Therapy0.706

Temporal TET2-Mediated Hydroxymethylation Cycling0.657

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.